NAVB: Message Board for Navidea Biopharmaceuticals, Inc. - InvestorVillage

Navidea Biopharmaceuticals, Inc.

  NAVB website

NAVB   /  Message Board

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous 2500 Messages Top of Message List
Go to Msg #  
MSG # SUBJECT TYPE AUTHOR SENTIMENT RECS DATE POSTED
33635 2021: Macrophages are a portal to breast cancer metastasis and appears from piecing together studies are formed by Mena pro angiogenic macrophages and endothelial cell cd206 mannose receptor M2 in the TME GN moneyonomics 3 1/26/2021 9:04:10 PM
33634 Anyone heard from z3peru....hope okay..eom GN moneyonomics 3 1/25/2021 11:42:49 PM
33633 How is Lymphoseek being used in breast cancer surgery advancements such as the SCOUT® Radar Localization System GN moneyonomics 7 1/25/2021 11:38:28 PM
33632 TA TA co3aii 2 1/25/2021 3:57:08 PM
33631 Siamon Gordon MT/NAVB SAB:50 years later where are we?..now in a position to decipher functions of macrophages in every tissue..possible manipulation for therapeutic purposes, converting tumor-promoting trophic macrophage..to..cytocidal one or converse... GN moneyonomics 5 1/24/2021 9:15:10 PM
33630 Sends positive signal for RA Dx P3 plans! Confirmation today on how difficult it was/strong accomplishment it was for the RA Dx P2b to be completed in ~21 original planned months! GN moneyonomics 7 1/22/2021 9:06:57 PM
33629 RE: ICR....internal lab resolved issues with molecule...patents issued...KS ongoing as oncology proof and other pre clinicals in process with some funding...~2 years to unfold therapeutics...most view this as the big reach to be invested for...eom GN moneyonomics 5 1/21/2021 4:38:05 PM
33628 ICR: Jan 14, 2021 completing RA Dx P2b arm 3, 16 patient data package, to be used in next several days to move forward with FDA. Will FDA 60 calander day review period end up to be 3, 4, 5, 6, 7, 8, or 9 weeks for response/meeting?...eom GN moneyonomics 4 1/21/2021 4:22:18 PM
33627 Re: What a Joke GN clintock 0 1/21/2021 2:28:22 PM
33626 ICR: RA Synovial Tissue comparison of quantitative TIL analysis of imaging vs Immunohistochemical from biopsy trial NAV3-32 to begin in Illinois beginning of Feb 2021..UK trail start pending for Covid clearance GN moneyonomics 7 1/20/2021 11:26:32 PM
Previous 2500 Messages Top of Message List
Go to Msg #  








Financial Market Data provided by
.
Loading...